Carbadox, the active ingredient in Mecadox ®, a Phibro Animal Health product, helps U.S. hog producers safely control bacterial diseases in early growth stages of pigs. Last week, the U.S. Food and Drug Administration took the first steps to take this valuable pharmaceutical away from the swine industry. Tom Burkgren, DVM and executive director of the American Association of Swine Veterinarians, says it is a very important product and there is no getting around it.
Source: National Hog Farmer, April 15, 2016.
In the process of reexamining the Mecadox products, the FDA is proposing to rescind the use of carbadox to treat swine because of concerns that the drug may leave trace amounts of a carcinogenic residue and the agency states that Phibro “has failed to provide sufficient scientific data to demonstrate the safety of this drug.” Phibro believes the FDA jumped the gun on making the announcement.
INSIGHTS: Consumer pressure, the upcoming VFD implementation and supply chain requirements are making U.S. animal protein production very challenging. Add in market volatility and a perfect storm is on the horizon. The only solution is to stay informed, share information and try to be the voices of reason. Animal Health Digest is a service tool you can share with colleagues, customers and partners in your respective channels of influence. Our job is to read and share important information, then deliver it to you for action. Share AHD today!